Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset...
17-Jun-2021 1:15 PM EDT Add to Favorites
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA...
15-Jun-2021 12:05 PM EDT Add to Favorites
A study led by researchers at Yale Cancer Center, Stony Brook University and KDx Diagnostics, Inc., examined a revolutionary new urine screening test that utilizes a novel Keratin 17 (K17) cancer biomarker, and revealed the test can detect the...
7-Jun-2021 6:40 PM EDT Add to Favorites
In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream...
22-Apr-2021 4:30 PM EDT Add to Favorites
In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL)...
19-Apr-2021 8:00 AM EDT Add to Favorites
Researchers Identify New Role for Immune-Boosting Protein “STING” in Treatment of Head and Neck Cancer
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING. STING has traditionally been implicated in the immune response to DNA damage, however, in this study, the focus is on...
19-Apr-2021 9:00 AM EDT Add to Favorites
Researchers Identify Genes Behind Uterine Leiomyosarcoma Which May Be Treated Using Precision Medicine
In a new study, Yale Cancer Center researchers have defined the genetic landscape of uterine leiomyosarcomas (uLMS).
5-Apr-2021 4:00 PM EDT Add to Favorites
Cecelia Calhoun Named Director of the Adolescent-Young Adult Sickle Cell Program at Yale Cancer Center and Smilow Cancer Hospital
Cecelia Calhoun, MD, MSPH, MBA, has been appointed Assistant Professor of Medicine (Hematology) and Assistant Professor of Pediatrics (Hematology/Oncology) at Yale Cancer Center and Smilow Cancer Hospital
23-Mar-2021 2:50 PM EDT Add to Favorites
See All News
Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT
Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT
Utilizing Information Technology to Address Oral Chemotherapy Challenges
26-Mar-2018 2:05 PM EDT
12-Mar-2018 3:05 PM EDT
For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT
6-Oct-2017 3:05 PM EDT
6-Oct-2017 2:05 PM EDT
22-Sep-2017 4:30 PM EDTSee All Experts